Home-based medication review in a high risk elderly population in primary care—the POLYMED randomised controlled trial
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess whether home-based medication review by a pharmacist for at-risk older patients in a primary care setting can reduce hospital admissions. DESIGN: Randomised controlled trial comparing home-based medication review with standard care. SETTING: Home-based medication review of 136 patients registered with one general practice. METHOD: Study participants were over 80 years of age, living at home, taking four or more medicines, and had at least one additional medicines-related risk factor. The intervention comprised two home visits by a community pharmacist who educated the patient/carer about their medicines, noted any pharmaceutical care issues, assessed need for an adherence aid, and subsequently met with the lead GP to agree on actions. MAIN OUTCOME MEASURE: Total non-elective hospital admissions within 6 months. Secondary outcomes included number of deaths, care home admissions and quality of life (EQ-5d). Impact on number of medicines prescribed was also assessed. RESULTS: At 6 months, no difference in hospital admissions (21 intervention versus 20 control P = 0.80), and no difference in care home admissions or deaths were detected between groups. There was a small (non-significant) decrease in quality of life in the intervention group. There was a statistically significant reduction in the mean number of medicines prescribed ( -0.87 items in favour of the intervention group, 95% confidence interval -1.66 to -0.08, P = 0.03). CONCLUSIONS: No positive impact on clinical outcomes or quality of life was demonstrated, however, this intervention did appear to reduce prescribing. This is in line with other evidence and suggests that this form of intervention may not have a clear health gain, but may lead to modest savings in terms of reduced prescribing. Future research should focus on whether such a prescribing effect would make this type of intervention cost effective.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Research evaluating the impact of collaborative medication reviews indicates that such services improve prescribing, and have the potential to reduce health service use and medication costs for patients with multiple chronic conditions [18,19].”
From From “retailers” to health care providers: Transforming the role of community pharmacists in chronic disease management (2015) · cites this paper as [18]
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
National Service Framework for Older People
Baldwin, R. C. (2003) · Psychiatric Bulletin · doi:10.1192/pb.27.4.121 · Cited by 1,038
Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care
Krska, J. (2001) · Age and Ageing · doi:10.1093/ageing/30.3.205 · Cited by 359 · cited 1×
“Trials of medication review [9, 10], where the pharmacist had direct access to medication records and closer liaison with GPs, have reported better resolution of pharmaceutical care issues and potential cost savings.”
BackgroundTHE BRITISH JOURNAL OF CLINICAL PRACTICE
(1960) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1960.tb03817.x · Cited by 342
Holland, R., Lenaghan, E., Harvey, I., Smith, R., Shepstone, L., Lipp, A., Christou, M., Evans, D., & Hand, C. (2005) · BMJ · doi:10.1136/bmj.38338.674583.ae · Cited by 331 · cited 1×
“One of the largest of these [8] showed a”
BackgroundSelf-citationZermansky, A. G., Petty, D. R., Raynor, D. K., Freemantle, N., Vail, A., & Lowe, C. J. (2001) · BMJ · doi:10.1136/bmj.323.7325.1340 · Cited by 319 · cited 2×
“Two other large studies of this type undertaken in a primary care setting [16, 17] did not show any decrease in the number of prescribed medicines.”
BackgroundA pharmacy discharge plan for hospitalized elderly patients—a randomized controlled trial
Nazareth, I., Burton, A., Shulman, S., Smith, P., Haines, A., & Timberall, H. (2001) · Age and Ageing · doi:10.1093/ageing/30.1.33 · Cited by 189
Effects of Home‐Based Intervention on Unplanned Readmissions and Out‐of‐Hospital Deaths
Stewart, S., Pearson, S., Luke, C. G., & Horowitz, J. D. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb02535.x · Cited by 188 · cited 1×
“Data from a previous study [13] suggested that the level of hospital admissions could be reduced by as much as 25% over 6 months.”
BackgroundDOES ENCOURAGING GOOD COMPLIANCE IMPROVE PATIENTS' CLINICAL CONDITION IN HEART FAILURE?
Goodyer, L., Miskelly, F., & Milligan, P. (1995) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1995.tb09942.x · Cited by 122 · cited 1×
“In contrast, a number of trials have been published since ‘Polymed’ was initiated, which provide evidence in support of interventions that are focused in specific disease areas such as heart failure [14] or gastritis [15].”
BackgroundAl‐Eidan, F. A., McElnay, J. C., Scott, M. G., & McConnell, J. B. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01531.x · Cited by 99 · cited 1×
“In contrast, a number of trials have been published since ‘Polymed’ was initiated, which provide evidence in support of interventions that are focused in specific disease areas such as heart failure [14] or gastritis [15].”
Background
Cited by
Interventions to improve the appropriate use of polypharmacy for older people
Patterson, S. M., Cadogan, C. A., Kerse, N., Cardwell, C. R., Bradley, M. C., Ryan, C., & Hughes, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub3 · Cited by 754
Interventions to improve the appropriate use of polypharmacy for older people
Rankin, A., Cadogan, C. A., Patterson, S. M., Kerse, N., Cardwell, C. R., Bradley, M. C., Ryan, C., & Hughes, C. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub4 · Cited by 511
Mossialos, E., Courtin, E., Naci, H., Benrimoj, S., Bouvy, M., Farris, K., Noyce, P., & Sketris, I. (2015) · Health Policy · doi:10.1016/j.healthpol.2015.02.007 · Cited by 465
Jyrkkä, J., Enlund, H., Lavikainen, P., Sulkava, R., & Hartikainen, S. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2116 · Cited by 417
Holland, R., Desborough, J., Goodyer, L., Hall, S., Wright, D., & Loke, Y. K. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03071.x · Cited by 365
Self-citationManaging Medications in Clinically Complex Elders: “There's Got to Be a Happy Medium”
Steinman, M. A., & Hanlon, J. T. (2010) · JAMA · doi:10.1001/jama.2010.1482 · Cited by 319
Potentially inappropriate prescribing in an Irish elderly population in primary care
Ryan, C., O'Mahony, D., Kennedy, J., Weedle, P., & Byrne, S. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03531.x · Cited by 281
Cross, A. J., Elliott, R. A., Petrie, K., Kuruvilla, L., & George, J. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012419.pub2 · Cited by 249
Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis
Bloomfield, H. E., Greer, N., Linsky, A. M., Bolduc, J., Naidl, T., Vardeny, O., MacDonald, R., McKenzie, L., & Wilt, T. J. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06089-2 · Cited by 240
Johansson, T., Abuzahra, M. E., Keller, S., Mann, E., Faller, B., Sommerauer, C., Höck, J., Löffler, C., Köchling, A., Schuler, J., et al. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12959 · Cited by 234
Huiskes, V. J. B., Burger, D. M., van den Ende, C. H. M., & van den Bemt, B. J. F. (2017) · BMC Family Practice · doi:10.1186/s12875-016-0577-x · Cited by 227
Impact of Medication Reconciliation and Review on Clinical Outcomes
Lehnbom, E. C., Stewart, M. J., Manias, E., & Westbrook, J. I. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014543485 · Cited by 225
“In six studies, no statistically significant differences were found between intervention and control patients.(68,72,73,75,76,82) Intervention patients compared with control group patients in five other studies were found to have lower rates of hospital admission or readmissions.”
ResultGnjidic, D., Le Couteur, D. G., Kouladjian, L., & Hilmer, S. N. (2012) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2012.01.006 · Cited by 215
Interventions to improve the appropriate use of polypharmacy for older people
Patterson, S. M., Hughes, C., Kerse, N., Cardwell, C. R., & Bradley, M. C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub2 · Cited by 207
Blenkinsopp, A., Bond, C., & Raynor, D. K. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04331.x · Cited by 202
A systematic review and meta‐analysis of pharmacist‐led fee‐for‐services medication review
Hatah, E., Braund, R., Tordoff, J., & Duffull, S. B. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12140 · Cited by 191
The Role of the Pharmacist in Optimizing Pharmacotherapy in Older People
Spinewine, A., Fialová, D., & Byrne, S. (2012) · Drugs & Aging · doi:10.2165/11631720-000000000-00000 · Cited by 160
Geurts, M. M. E., Talsma, J., Brouwers, J. R. B. J., & de Gier, J. J. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04178.x · Cited by 159
“All studies with no differences in hospital admissions provided no additional training to pharmacists [10, 13, 15]; however, one study did mention that the intervention was performed by experienced pharmacists [13].”
BackgroundMayo-Wilson, E., Grant, S., Burton, J., Parsons, A., Underhill, K., & Montgomery, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089257 · Cited by 163
“Sixty-four studies reported in 86 citations were included in the narrative synthesis (Table S2) [23–108], but three of these did not report any outcomes that could be included in a meta-analysis [36,68,74].”
BackgroundThomas, R., Huntley, A. L., Mann, M. K., Huws, D., Elwyn, G. J., Paranjothy, S., & Purdy, S. (2013) · Age and Ageing · doi:10.1093/ageing/aft169 · Cited by 142
“After review of the full papers against the inclusion and exclusion criteria, a total of 20 trials were included [11–30].”
BackgroundMethodInfluentialLenander, C., Elfsson, B., Danielsson, B., Midlöv, P., & Hasselström, J. (2014) · Scandinavian Journal of Primary Health Care · doi:10.3109/02813432.2014.972062 · Cited by 152
Kuntz, J. L., Safford, M. M., Singh, J. A., Phansalkar, S., Slight, S. P., Her, Q. L., Lapointe, N. A., Mathews, R., O’Brien, E., Brinkman, W. B., et al. (2014) · Patient Education and Counseling · doi:10.1016/j.pec.2014.08.021 · Cited by 118
“The majority of these interventions (eight of 12 studies) focused on medication-taking [39;41;44–46;49;50], while three addressed effective prescribing [42;47;48] and two centered on effective feedback [40;43].”
Bouton, C., Journeaux, M., Jourdain, M., Angibaud, M., Huon, J., & Rat, C. (2023) · BMC Family Practice · doi:10.1186/s12875-023-02189-0 · Cited by 148
“Conversely, some randomized trials concluded that there was no impact on their primary outcome measure [51, 53, 57, 60].”
BackgroundKwint, H., Bermingham, L. W., Faber, A., Gussekloo, J., & Bouvy, M. L. (2013) · Drugs & Aging · doi:10.1007/s40266-012-0048-6 · Cited by 122
“Six of these studies reported on quality of life measured using the 36-item Short Form Health Survey (SF-36) [3, 17, 19, 26, 27, 29, 32] or the EuroQoL-5D/visual analogue scale (VAS) [25].”
BackgroundMethodInfluentialPrimary care and care for older persons: position paper of the European Forum for Primary Care.
Boeckxstaens, P., & Graaf, P. D. (2011) · PubMed · Cited by 159
Polypharmacy and the management of the older cancer patient
Balducci, L., Goetz-Parten, D. E., & Steinman, M. A. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt266 · Cited by 127
Radcliffe, E., Servin, R., Cox, N. J., Lim, S. E. R., Tan, Q. Y., Howard, C., Sheikh, C., Rutter, P. M., Latter, S. M., Lown, M. T., et al. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04256-8 · Cited by 127
Pharmacist services for non-hospitalised patients
de Barra, M., Scott, C., SCOTT, N. W., Johnston, M., de Bruin, M., Nkansah, N., Bond, C. M., Matheson, C., Rackow, P., Williams, A. J., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013102 · Cited by 131
Polypharmacy among inpatients aged 70 years or older in Australia
Hubbard, R. E., Peel, N. M., Scott, I. A., Martin, J. H., Smith, A., Pillans, P. I., Poudel, A., & Gray, L. C. (2015) · Medical Journal of Australia · doi:10.5694/mja13.00172 · Cited by 107
Interventions to reduce unplanned hospital admission: a series of systematic reviews
Purdy, S., Paranjothy, S., Huntley, A. L., Thomas, R., Mann, M. K., Huws, D., Brindle, P. M., & Elwyn, G. J. (2012) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 127
Chau, S. H., Jansen, A. P. D., van de Ven, P. M., Hoogland, P., Elders, P. J. M., & Hugtenburg, J. G. (2015) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-015-0199-8 · Cited by 104
“Higher implementation rates have also been found in studies focussing on selected DRPs [19] or in studies in which only a limited number of interventions were proposed [22].”
BackgroundBryant, L. J. M., Coster, G., Gamble, G. D., & McCormick, R. (2011) · International Journal of Pharmacy Practice · doi:10.1111/j.2042-7174.2010.00079.x · Cited by 99
“The studies of community-pharmacy-based general, rather than disease-specific, medication reviews have been less successful,([10,40,47,48]) although clinical medication review studies provided in pharmacist clinics, using a CPC-type process, were positive.”
ResultHansen, C. R., O’Mahony, D., Kearney, P. M., Sahm, L. J., Cullinan, S., Huibers, C. J. A., Thevelin, S., Rutjes, A. W., Knol, W., Streit, S., et al. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13742 · Cited by 88
Cárdenas‐Valladolid, J., Martín-Madrazo, C., Salinero-Fort, M. Á., Pau, E. C. D. S., Abánades-Herranz, J. C., & de Burgos‐Lunar, C. (2010) · Drugs & Aging · doi:10.2165/11537320-000000000-00000 · Cited by 93
Khalil, H., Bell, B., Chambers, H. P., Sheikh, A., & Avery, A. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003942.pub3 · Cited by 94
Mohammed, M. A., Moles, R. J., & Chen, T. F. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016656016 · Cited by 75
Zechmann, S., Senn, O., Valeri, F., Essig, S., Merlo, C., Rosemann, T. J., & Neuner‐Jehle, S. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01870-8 · Cited by 73
The evidence for services to avoid or delay residential aged care admission: a systematic review
Luker, J. A., Worley, A., Stanley, M. J., Uy, J., Watt, A. M., & Hillier, S. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1210-3 · Cited by 67
Beuscart, J., Pont, L., Thevelin, S., Boland, B. B., Dalleur, O., Rutjes, A. W., Westbrook, J. I., & Spinewine, A. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13197 · Cited by 73
Barry, H. E., Cooper, J. A., Ryan, C. A., Passmore, A. P., Robinson, A. L., Molloy, G. J., Darcy, C., Buchanan, H., & Hughes, C. M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151177 · Cited by 63
Croke, A., Cardwell, K., Clyne, B., Moriarty, F., McCullagh, L., & Smith, S. M. (2023) · BMC Family Practice · doi:10.1186/s12875-022-01952-z · Cited by 60
“Review secondary outcomes included 15 studies (16 articles) which reported on HRQoL; nine studies reported Short Form 36 Health Survey Questionnaire (SF-36) (33, 34, 36, 37, 40, 48, 52-54) and six studies (seven articles) reported EuroQol-5D (EQ5D) (41, 42, 45, 46, 49, 50, 55).”
BackgroundInfluentialPolypharmacy and Food–Drug Interactions Among Older Persons: A Review
Heuberger, R. (2012) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2012.729902 · Cited by 58
Angibaud, M., Jourdain, M., Girard, S., Rouxel, L., Mouhib, A., Nogueira, A., Rat, C., & Huon, J. (2024) · BMC Family Practice · doi:10.1186/s12875-024-02326-3 · Cited by 62
“Eight studies evaluated a collaborative pharmacist intervention for six months [25, 28, 32, 36, 37, 39–41] and eight studies for more than 12 months [26, 27, 29–31, 33, 34, 42].”
BackgroundMethodInfluentialImpact of pharmaceutical care on adherence, hospitalisations and mortality in elderly patients
Olesen, C., Harbig, P., Buus, K. M., Barat, I., & Damsgaard, E. M. S. (2013) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-013-9898-1 · Cited by 57
“Four studies observed similar mortality rates [4, 8, 14, 17].”
Medication review and patient counselling at discharge from the hospital by community pharmacists
Hugtenburg, J. G., Borgsteede, S. D., & Beckeringh, J. J. (2009) · Pharmacy World & Science · doi:10.1007/s11096-009-9314-z · Cited by 57
Reducing hospital bed use by frail older people: results from a systematic review of the literature
Philp, I., Mills, K. A., Long, J. F., Thanvi, B., & Ghosh, K. (2013) · International Journal of Integrated Care · doi:10.5334/ijic.1148 · Cited by 54
“[19] N”
InfluentialDawoud, D., Haines, A., Wonderling, D. E., Ashe, J., Hill, J., Varia, M., Dyer, P., & Bion, J. (2019) · PharmacoEconomics · doi:10.1007/s40273-019-00814-4 · Cited by 53
Mehuys, E., Dupond, L., Petrović, M., Christiaens, T., Bortel, L. M. V., Adriaens, E., Bolle, L. D., Tongelen, I. V., Remon, J. P., & Boussery, K. (2012) · The journal of nutrition health & aging · doi:10.1007/s12603-012-0028-x · Cited by 51
“The already published pharmacy studies report on home-based medication reviews aimed at improving the appropriateness of prescribing (7-11).”
Ryan, C. A., O’Mahony, D., O’Donovan, D. Ó., O’Grady, E., Weedle, P., Kennedy, J., & Byrne, S. (2012) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-012-9733-0 · Cited by 49
“Pharmacist-led MURs have demonstrated a potential economic saving [17] and a reduction in polypharmacy [18].”
BackgroundLoh, Z. W. R., Cheen, M. H. H., & Wee, H. L. (2016) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12453 · Cited by 48
Medication Therapy Management after Hospitalization in CKD: A Randomized Clinical Trial
Tuttle, K. R., Alicic, R. Z., Short, R., Neumiller, J. J., Gates, B. J., Daratha, K. B., Barbosa‐Leiker, C., McPherson, S., Chaytor, N. S., Dieter, B. P., et al. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06790617 · Cited by 49
Duan‐Porter, W., Ullman, K. E., Rosebush, C. E., McKenzie, L. G., Ensrud, K. E., Ratner, E. R., Greer, N. L., Shippee, T. P., Gaugler, J. E., & Wilt, T. J. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05568-5 · Cited by 45
Wagle, K. C., Skopelja, E. N., & Campbell, N. L. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15556 · Cited by 46
“Only 3 of the 8 selected studies reported clinical outcomes such as fewer medicines, change in hospitalization, change in adverse outcomes, difference in use of inappropriate medications, or medication adherence.(15,19,20) Multicomponent collaborative interventions that included medication management improved rehospit…”
BackgroundBabar, Z., Kousar, R., Murtaza, G., Azhar, S., Khan, S. A., & Curley, L. E. (2017) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2017.06.008 · Cited by 43
Evaluation of drug‐related problems in older polypharmacy primary care patients
Kovačević, S. V., Miljković, B., Ćulafić, M., Kovačević, M., Golubović, B., Jovanović, M., Vučićević, K. M., & de Gier, J. J. (2017) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12737 · Cited by 42
“It has been argued that medication review services are time‐consuming and are not likely to be cost‐effective in all older patients.(11) Therefore, identifying and targeting patients with predictive factors for DRPs may yield better outcomes of the service.”
BackgroundMalham, C. B., Khatib, S. E., Cestac, P., Andrieu, S., Rouch, L., & Salameh, P. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14864 · Cited by 44
Abbott, R. A., Moore, D. A., Rogers, M., Bethel, A. C., Stein, K., & Coon, J. T. (2020) · BMC Health Services Research · doi:10.1186/s12913-019-4728-3 · Cited by 39
Frailty: a key indicator to minimize inappropriate medication in older people
Poudel, A., Hubbard, R. E., Nissen, L. M., & Mitchell, C. (2013) · QJM · doi:10.1093/qjmed/hct146 · Cited by 44
“Similarly, the PLOYMED randomized controlled trial of pharmacist-led medication review showed no positive impact on clinical outcomes or quality of life.(31) Only a medication review underpinned by careful consideration of the health status of the patient concerned, including estimation of life expectancy and explorat…”
BackgroundKelly, W. N., Ho, M.-J., Smith, T., Bullers, K., & Kumar, A. (2023) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2023.04.024 · Cited by 39
Zermansky, A. G., & Silcock, J. (2009) · PharmacoEconomics · doi:10.2165/00019053-200927010-00003 · Cited by 38
“3.9 Lenaghan et al., 2007 This small RCT of 136 patients was conducted to determine whether pharmacist intervention reduced non-elective hospital admissions.”
BackgroundInfluentialPatient focused drug surveillance of elderly patients in nursing homes
Olsson, I. N., Curman, B., & Engfeldt, P. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1891 · Cited by 34
Bhattacharya, D., Aldus, C. F., Barton, G., Bond, C. M., Boonyaprapa, S., Charles, I. S., Fleetcroft, R., Holland, R., Jerosch‐Herold, C., Salter, C., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20500 · Cited by 34
“The findings of this study are in agreement with others designed to promote adherence which have reported increased mortality and health-care costs for participants receiving the intervention.(110,111) It is intuitive that increasing adherence to a medication without reflecting on the implications of an increased dosa…”
ResultSelf-citationCheen, M. H. H., Goon, C. P., Ong, W. C., Lim, P. S., Wan, C. N., Leong, M. Y., & Khee, G. Y. (2016) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzw150 · Cited by 33
Investigating general practitioner engagement with pharmacists in Home Medicines Review
Costa, D. S. J., Van, C., Abbott, P., & Krass, I. (2015) · Journal of Interprofessional Care · doi:10.3109/13561820.2015.1012253 · Cited by 33
Roncal‐Belzunce, V., Gutiérrez‐Valencia, M., Leache, L., Saiz, L. C., Bell, J. S., Erviti, J., & Martínez‐Velilla, N. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102317 · Cited by 34
Mizokami, F., Mizuno, T., Kanamori, K., Oyama, S., Nagamatsu, T., Lee, J. K., & Kobayashi, T. (2019) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13796 · Cited by 31
“…Messerli et al. 2016, Switzerland20 Outpatients II IG (n = 218), CG (n = 232) IG: 67 years, CG: 67 years IG: 6.8, CG: 6.8 4 months No 1.08 (0.75–1.54) Lenaghan et al. 2007, UK26 Outpatients II IG (n = 69), CG (n = 67) IG: 85 years, CG: 84 years IG: 9.9, CG: 9.0 6 months No 1.02 (0.61–1.70)…”
InfluentialCurrent perspectives on pharmacist home visits: do we keep reinventing the wheel?
Flanagan, P. S., & Barns, A. (2018) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s148266 · Cited by 31
“Receiving referrals from a physician may not only impact the longevity of a HV program,(68) but also may result in more collaboration for making medication changes through case conferences.(15,53,71) However, receiving referrals for a pharmacist HV intervention may not occur, despite being recommended.”
BackgroundInfluentialKelly, W. N., Ho, M.-J., Bullers, K., Klocksieben, F. A., & Kumar, A. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2021.01.028 · Cited by 30
Signs and Symptoms Indicative of Potential Adverse Drug Reactions in Homecare Patients
Sino, C. G. M., Bouvy, M. L., Jansen, P. A. F., Schop, I. M. B., Egberts, T. C. G., & Schuurmans, M. J. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.09.014 · Cited by 29
Clinical Pharmacy Services in the Home
MacKeigan, L. D., & Nissen, L. M. (2008) · Disease Management & Health Outcomes · doi:10.2165/00115677-200816040-00004 · Cited by 28
Persaud, N., Workentin, A., Rizvi, A., Pierson, T., Bortolussi‐Courval, É., Liu, K., Bennett, A., Shaver, N., Skidmore, B., Vyas, N., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.17965 · Cited by 31
James, M. M., Faria, R., Wong, R., & Scope, A. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14368 · Cited by 29
“Topic: Efficient handover between primary and secondary care (2 UK studies out of 25) Redmond et al(49) ≥5 medications 25 (2) • Cadman et al was an RCT comparing a standardised operating procedure based on hospital guidelines to deliver medication reviews by trained MRP within 24 hours of admission and at point of tra…”
MethodHurmuz, M. Z. M., Janus, S. I. M., & van Manen, J. G. (2018) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-018-0602-3 · Cited by 26
“This idea is supported by one study in high-risk patients [17] in which an effect was observed on the total number of prescribed medication.”
ResultMedication management in older adults: a critique of concordance
Snowden, A. (2008) · British Journal of Nursing · doi:10.12968/bjon.2008.17.2.28140 · Cited by 28
Completeness of medication reviews provided by community pharmacists
Kwint, H. F., Faber, A., Gussekloo, J., & Bouvy, M. L. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12132 · Cited by 24
Verdoorn, S., Kwint, H., Blom, J. W., Gussekloo, J., & Bouvy, M. L. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0877-1 · Cited by 30
Adverse drug reactions in older people
Tangiisuran, B., Gozzoli, M., Davies, J., & Rajkumar, C. (2010) · Reviews in Clinical Gerontology · doi:10.1017/s0959259810000171 · Cited by 30
Hamano, J., Ozone, S., & Tokuda, Y. (2015) · BMC Health Services Research · doi:10.1186/s12913-015-0732-4 · Cited by 22
“One previous study conducted in home care settings revealed that a medication review by a community pharmacist could reduce the number of medications, but it was not clear about the relations of pharmacist intervention to drug costs of PIMs [31].”
BackgroundOVERVIEW OF EVIDENCE RELATING TO SHIFTING THE BALANCE OF CARE: A CONTRIBUTION TO THE KNOWLEDGE BASE
Johnston, L., Lardner, C., & Jepson, R. G. (2008) · Cited by 28
Craske, M. E., Hardeman, W., Steel, N., & Twigg, M. J. (2024) · BMJ Quality & Safety · doi:10.1136/bmjqs-2024-017283 · Cited by 21
Huiskes, V. J. B., van den Ende, C. H. M., Kruijtbosch, M., Ensing, H. T., Meijs, M., Meijs, V. M. M., Burger, D. M., & van den Bemt, B. J. F. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14125 · Cited by 21
“Furthermore most published RCTs on medication review as the single intervention showed no or little effect on clinical outcomes, such as hospital (re-) admissions and mortality.(13-18) One possible explanation for the limited effect of medication review on clinical outcomes such as hospital (re)admissions and mortalit…”
BackgroundPrävention unerwünschter Arzneimittelwirkungen bei älteren Patienten
Burkhardt, H., Wehling, M., & Gladisch, R. (2007) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-007-0468-9 · Cited by 23
“So konnte zum Beispiel eine kürzlich erschienene britische Untersuchung gegen die Erwartungen keinen signifikanten positiven Effekt einer aufwändigen mindestens zweimal im häuslichen Bereich erfolgten Beratung und Schulung älterer Patienten nachweisen [54] was die Frequenz erneuter Krankenhausaufnahmen anbelangte.”
BackgroundA rapid review of interventions to improve medicine self‐management for older people living at home
Previdoli, G., Cheong, V., Alldred, D. P., Tomlinson, J., Tyndale‐Biscoe, S., Silcock, J., Okeowo, D. A., & Fylan, B. (2023) · Health Expectations · doi:10.1111/hex.13729 · Cited by 21
Pharmacist-led medication reviews in primary care
Desborough, J., & Twigg, M. J. (2013) · Reviews in Clinical Gerontology · doi:10.1017/s0959259813000233 · Cited by 23
Ulfvarson, J., Rahmner, P. B., Fastbom, J., Sjöviker, S., & Karlsson, E. (2010) · International Journal of Health Care Quality Assurance · doi:10.1108/09526861011060933 · Cited by 20
“The traditional model is when a pharmacist together with the caregiver, systematically evaluates a patient's drug treatment ( Lenaghan et al. , 2007”
BackgroundPapastergiou, J., Luen, M., Tencaliuc, S., Li, W., van den Bemt, B. J. F., & Houle, S. K. D. (2019) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163519861420 · Cited by 19
Meid, A. D., Wirbka, L., Moecker, R., Ruff, C., Weißenborn, M., Haefeli, W. E., & Seidling, H. M. (2023) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2023.0014 · Cited by 23
Anderson, M., & Francetic, I. N. ;. (2024) · British Journal of General Practice · doi:10.3399/bjgp.2024.0320 · Cited by 17
Home Visits for Prevention of Impairment and Death in Older Adults: A Systematic Review
Grant, S., Parsons, A., Burton, J., Montgomery, P., Underhill, K., & Wilson, E. (2014) · Campbell Systematic Reviews · doi:10.4073/csr.2014.3 · Cited by 17
Kyle, G. J., Nissen, L. M., & Tett, S. E. (2008) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2008.00948.x · Cited by 17
Programa de atención farmacéutica integrada en pacientes con enfermedades crónicas
Gorgas, M. Q., Vives, F., Ramió, J. C., Cabrera, E. D. P., Santasusagna, P. J., Peipoch, E. H., Schoenenberger-Arnaiz, J. A., Jané, C. C., & Gómez-Arbonés, J. (2011) · Farmacia Hospitalaria · doi:10.1016/j.farma.2011.06.015 · Cited by 17
The effects of a pharmacist-led medication review in a nursing home: A randomized controlled trial.
Liou, W., Huang, S.-M., Lee, W.-H., Chang, Y.-L., & Wu, M. (2021) · PubMed Central · doi:10.1097/md.0000000000028023 · Cited by 8
Jang, S., Jeong, S., & Jeong, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112305 · Cited by 16
Szilvay, A., Somogyi, O., Meskó, A., Zelkó, R., & Hankó, B. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4114-1 · Cited by 16
Abrahamsen, B., Hansen, R. N., & Rossing, C. (2020) · Pharmacy Practice · doi:10.18549/pharmpract.2020.4.1976 · Cited by 15
“For subgroups based on patient characteristics, seven studies for frail patients were included.(37-43) The group can be further divided into patients in care homes or homedwelling.”
BackgroundMethodInfluentialImproving Heart Failure Outcomes with Pharmacist–Physician Collaboration: How Close are we?
Ellett, L. M. K., Roughead, E. E., & Gilbert, A. L. (2010) · Future Cardiology · doi:10.2217/fca.09.67 · Cited by 15
Crutzen, S., Schuling, J., Hugtenburg, J. G., Verduijn, M. M., Teichert, M., Taxis, K., & Denig, P. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00217 · Cited by 15
“, 2014), although effects on outcomes like hospital admissions or quality of life have not been consistently demonstrated (Holland et al., 2005, 2008; Lenaghan et al., 2007; Hatah et al., 2014; Huiskes et al., 2017; Hurmuz et al., 2018).”
BackgroundPerceived Value of a Home-Based Medication Therapy Management Program for the Elderly
Moultry, A. M., & Poon, I. O. (2008) · The Consultant Pharmacist · doi:10.4140/tcp.n.2008.877 · Cited by 14
Margolis, S. A., Gonzalez, J. S., Spindell, J., Mohamadpour, M., Grant, A. C., & Nakhutina, L. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.09.022 · Cited by 14
Reumerman, M. O., Richir, M. C., Sultan, R., Daelmans, H. E. M., Springer, H., Grijmans, E., Muller, M., van Agtmael, M. A., & Tichelaar, J. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2069748 · Cited by 13
“Another strength of our study is the relatively low cost of the student-led teams compared with most physician- or pharmacist-led interventions in community dwelling outpatients, which are often not cost-effective [38,39].”
Result
Metadata
- Authors
- Lenaghan, E., Holland, R., & Brooks, A.
- Affiliations
- University of East Anglia (GB)
- Kelling Hospital (GB)
- Corresponding author
- Lenaghan, E.
- ORCID
- Holland, R.
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-03-26
- Volume
- 36
- Issue
- 3
- Pages
- 292-297
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- OpenAlex
- W2147463647
- Cited by
- 182
- References
- 14
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 12 · 2023: 24 · 2022: 4 · 2021: 10 · 2020: 17 · 2019: 8 · 2018: 13 · 2017: 5 · 2016: 10 · 2015: 7 · 2014: 9 · 2013: 11 · 2012: 15
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Age and Ageing (publishedVersion)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Keywords
- community pharmacy, older adults, hospitalization, prescribing reduction, pharmaceutical care, polypharmacy, quality of life, nursing home admission, primary care
- MeSH terms
- Aged, 80 and over, Community Pharmacy Services, England, Homes for the Aged, House Calls, Humans, Mortality, Outcome and Process Assessment, Health Care, Patient Admission, Patient Care Team, Patient Compliance, Patient Education as Topic, Primary Health Care, Quality of Life, Risk Factors, Poisson Distribution, Caregivers, Drug Utilization Review, Polypharmacy, Interdisciplinary Communication
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.